Clinical care. At-home diagnostics. One app.
eMed is easy to start, & even easier to stick to
A GLP-1 program built to maximize adherence — and bend your healthcare cost curve
24/7 Clinical Support
Personalized Guidance
Continuous Adherence Monitoring
PROVEN OUTCOMES
Industry leading adherence. Real results. Measured from day one
prediabetes risk
Among members with HbA1C
>5.7% at enrollment*
triglycerides
Among members at >150 mg/dL at enrollment
high cholesterol
Among members at >240 mg/dL at enrollment
Starting average:
215 lbs
Source: Aon Workforce-Focused Analysis on GLP-1s, Phase Two Findings; January 13, 2026
*Among matched lab cohort participants with available data, observed reduction in the proportion with HbA1c above 5.7% over the measurement period.Individual results vary. Outcomes are not guaranteed
“High-quality medical care should be accessible to everyone, across different life stages, health goals, and needs.”
Tom Brady
eMed Chief Wellness Officer
You’ve got GLP-1 coverage challenges. eMed has solutions.
Our program takes on the biggest challenges in GLP-1 coverage: inflated pricing, access barriers, low adherence, and poor outcomes.
Lower Cost
Reduce clinical cost of care and get direct pricing on FDA-approved medications with no PBM markups, no rebate inflation and no surprises.
More Control
You set the employee contribution. You manage utilization. You own the outcome.
High Adherence
At-home diagnostics, 24/7 support, and ongoing progress tracking keep members engaged — and on track.
Guaranteed Outcomes
We guarantee employee weight loss and adherence. If we miss, you pay less.
eMed’s unique At Home Screening Kit makes it easy to help the most at-risk members
Most GLP-1 programs simply prescribe medication. eMed built a clinical intake process that creates broader population health intelligence.
Our clinicians screen for key biomarkers and help members get a clearer picture on their health.
Screens for and monitors diabetes; reflects average blood glucose over 2–3 months.
Simple, reproducible indicator of kidney filtration.
Biomarker for systemic inflammation in cardiovascular risk assessment.
Sensitive marker of hepatobiliary dysfunction and oxidative stress.
Screens for dyslipidemia; assesses cardiovascular risk via cholesterol levels (TC, LDL, HDL).
Screens for megaloblastic anemia and GLP-1 related nutritional deficiencies.
What others are saying about eMed
"When you see the benefits GLP-1 medications bring to the people you work with every day, it underscores how the decisions employers make today shape the future of colleague health, wellbeing and productivity and drive sustainable business performance and growth.”
.avif){kind=logo}
Real people. Real results.
Hear directly from eMed members about what it felt like to finally have a program that worked, and what life looks like on the other side.
Our Partners
Whether you're building a better benefits package or a better you, eMed can help.
